Catherine Kreatsoulas, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Headache Disorders, Primary | 1 | 2023 | 35 | 0.930 |
Why?
|
Men's Health | 2 | 2013 | 72 | 0.900 |
Why?
|
Women's Health | 4 | 2019 | 2029 | 0.860 |
Why?
|
Angina Pectoris | 3 | 2013 | 976 | 0.750 |
Why?
|
Estrogen Replacement Therapy | 2 | 2019 | 1203 | 0.690 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2019 | 128 | 0.640 |
Why?
|
Menopause | 2 | 2019 | 1613 | 0.630 |
Why?
|
Strabismus | 1 | 2021 | 269 | 0.600 |
Why?
|
Social Class | 3 | 2015 | 1974 | 0.530 |
Why?
|
Coronary Angiography | 5 | 2021 | 4560 | 0.530 |
Why?
|
Disabled Persons | 1 | 2023 | 1207 | 0.470 |
Why?
|
Coronary Artery Disease | 4 | 2021 | 6416 | 0.450 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 15070 | 0.370 |
Why?
|
Selection Bias | 1 | 2009 | 370 | 0.300 |
Why?
|
Income | 1 | 2015 | 1877 | 0.290 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1407 | 0.270 |
Why?
|
Primary Prevention | 1 | 2013 | 1165 | 0.260 |
Why?
|
Referral and Consultation | 2 | 2017 | 3514 | 0.210 |
Why?
|
Sex Factors | 4 | 2021 | 10398 | 0.190 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 821 | 0.160 |
Why?
|
Poverty | 1 | 2010 | 2626 | 0.160 |
Why?
|
Risk Factors | 9 | 2023 | 71974 | 0.160 |
Why?
|
Delphi Technique | 1 | 2021 | 770 | 0.160 |
Why?
|
Chronic Disease | 1 | 2013 | 9133 | 0.150 |
Why?
|
Acute Coronary Syndrome | 1 | 2010 | 2331 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2013 | 9812 | 0.140 |
Why?
|
Coronary Disease | 2 | 2009 | 6068 | 0.140 |
Why?
|
Decision Making | 1 | 2010 | 3854 | 0.140 |
Why?
|
Headache | 1 | 2023 | 1199 | 0.130 |
Why?
|
Needs Assessment | 2 | 2019 | 1145 | 0.130 |
Why?
|
Canada | 2 | 2010 | 2021 | 0.130 |
Why?
|
Research Design | 2 | 2017 | 5959 | 0.130 |
Why?
|
Spironolactone | 1 | 2017 | 378 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2019 | 576 | 0.120 |
Why?
|
Prevalence | 3 | 2019 | 15153 | 0.120 |
Why?
|
Ontario | 3 | 2009 | 375 | 0.110 |
Why?
|
Sweating | 1 | 2013 | 123 | 0.110 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 813 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 124 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 2913 | 0.100 |
Why?
|
Humans | 23 | 2023 | 739398 | 0.100 |
Why?
|
Food Supply | 1 | 2017 | 509 | 0.100 |
Why?
|
Female | 17 | 2021 | 378853 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2017 | 734 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2017 | 1078 | 0.100 |
Why?
|
Middle Aged | 11 | 2021 | 212863 | 0.100 |
Why?
|
Developing Countries | 2 | 2015 | 2779 | 0.090 |
Why?
|
Muscle Weakness | 1 | 2013 | 412 | 0.090 |
Why?
|
Population Groups | 1 | 2010 | 207 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7726 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2216 | 0.080 |
Why?
|
Male | 15 | 2021 | 349022 | 0.080 |
Why?
|
Immunoglobulin Fab Fragments | 2 | 2001 | 482 | 0.080 |
Why?
|
Risk Assessment | 2 | 2021 | 23294 | 0.080 |
Why?
|
Urinary Incontinence | 1 | 2013 | 490 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2629 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2265 | 0.080 |
Why?
|
Heart | 1 | 2021 | 4466 | 0.080 |
Why?
|
Age Distribution | 1 | 2013 | 2904 | 0.080 |
Why?
|
Educational Status | 1 | 2015 | 2514 | 0.080 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2001 | 641 | 0.080 |
Why?
|
Developed Countries | 1 | 2010 | 433 | 0.080 |
Why?
|
Aged | 8 | 2021 | 162698 | 0.070 |
Why?
|
Chest Pain | 1 | 2013 | 1112 | 0.070 |
Why?
|
Fatigue | 1 | 2013 | 1524 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1930 | 0.070 |
Why?
|
Dyspnea | 1 | 2013 | 1295 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2004 | 1874 | 0.060 |
Why?
|
Hyperlipidemias | 1 | 2009 | 785 | 0.060 |
Why?
|
Neoplasms | 1 | 2013 | 21507 | 0.060 |
Why?
|
United States | 4 | 2019 | 69573 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1364 | 0.060 |
Why?
|
World Health Organization | 1 | 2010 | 1321 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1849 | 0.060 |
Why?
|
Life Expectancy | 1 | 2010 | 1208 | 0.060 |
Why?
|
Survivors | 1 | 2013 | 2280 | 0.060 |
Why?
|
Age Factors | 2 | 2010 | 18349 | 0.060 |
Why?
|
Creatine Kinase | 1 | 2004 | 694 | 0.050 |
Why?
|
Public Health | 1 | 2015 | 2587 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3575 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3401 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2013 | 1939 | 0.050 |
Why?
|
Primary Health Care | 1 | 2017 | 4537 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57650 | 0.050 |
Why?
|
Young Adult | 2 | 2019 | 56255 | 0.050 |
Why?
|
Troponin I | 1 | 2004 | 616 | 0.040 |
Why?
|
Coronary Care Units | 1 | 2001 | 214 | 0.040 |
Why?
|
Mental Health | 1 | 2013 | 2946 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20676 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2013 | 4212 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2001 | 3066 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9898 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15194 | 0.030 |
Why?
|
Schools, Public Health | 1 | 2015 | 22 | 0.030 |
Why?
|
Prognosis | 3 | 2013 | 28901 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2018 | 867 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19811 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2001 | 9259 | 0.030 |
Why?
|
Depression | 1 | 2013 | 7689 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2041 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 11699 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 8960 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 53037 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2247 | 0.030 |
Why?
|
Cohort Studies | 2 | 2013 | 40389 | 0.030 |
Why?
|
Work | 1 | 2013 | 191 | 0.030 |
Why?
|
Internal-External Control | 1 | 2013 | 362 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2001 | 2155 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2004 | 11668 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1453 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2110 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35326 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8431 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1222 | 0.020 |
Why?
|
Hemorrhage | 1 | 2001 | 3441 | 0.020 |
Why?
|
Aortic Valve | 1 | 2018 | 1900 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15036 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1483 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4211 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3620 | 0.020 |
Why?
|
Incidence | 3 | 2013 | 20913 | 0.020 |
Why?
|
Adult | 2 | 2017 | 213394 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 11985 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8669 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8275 | 0.010 |
Why?
|
Health Behavior | 1 | 2013 | 2624 | 0.010 |
Why?
|
Hematocrit | 1 | 2001 | 636 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1835 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10362 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2001 | 1421 | 0.010 |
Why?
|
Hemoglobins | 1 | 2001 | 1529 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 62693 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 40802 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23355 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2004 | 6871 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 12640 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 10247 | 0.010 |
Why?
|
Child | 1 | 2017 | 77033 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 12328 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2001 | 76631 | 0.000 |
Why?
|